Rhythm Pharmaceuticals, Inc. (RYTM) — SC 13D/A Filings
All SC 13D/A filings from Rhythm Pharmaceuticals, Inc.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
NEA 13 LP Adjusts Stake in Rhythm Pharmaceuticals
— Apr 30, 2024 Risk: medium
New Enterprise Associates 13, LP (NEA 13 GP) has amended its Schedule 13D filing regarding Rhythm Pharmaceuticals, Inc. as of April 30, 2024. The filing indicat -
Perceptive Advisors Amends Rhythm Pharma Stake
— Apr 17, 2024 Risk: medium
On April 17, 2024, Perceptive Advisors LLC, along with affiliated entities and individuals including Joseph Edelman, filed an amendment to their Schedule 13D. T -
Perceptive Advisors Amends Stake in Rhythm Pharmaceuticals
— Apr 3, 2024 Risk: medium
Perceptive Advisors LLC, through its affiliated entities including Perceptive Life Sciences Master Fund, Ltd., has amended its Schedule 13D filing regarding Rhy
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX